KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Intangibles (2016 - 2019)

Historic Intangibles for Arbutus Biopharma (ABUS) over the last 7 years, with Q2 2019 value amounting to $43.8 million.

  • Arbutus Biopharma's Intangibles fell 2525.45% to $43.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $43.8 million, marking a year-over-year decrease of 2525.45%. This contributed to the annual value of $43.8 million for FY2018, which is 2525.45% down from last year.
  • Arbutus Biopharma's Intangibles amounted to $43.8 million in Q2 2019, which was down 2525.45% from $43.8 million recorded in Q1 2019.
  • In the past 5 years, Arbutus Biopharma's Intangibles ranged from a high of $390.0 million in Q2 2015 and a low of $43.8 million during Q3 2018
  • Its 5-year average for Intangibles is $165.6 million, with a median of $99.4 million in 2016.
  • Data for Arbutus Biopharma's Intangibles shows a peak YoY increase of 949.82% (in 2016) and a maximum YoY decrease of 7180.0% (in 2016) over the last 5 years.
  • Over the past 5 years, Arbutus Biopharma's Intangibles (Quarter) stood at $352.6 million in 2015, then plummeted by 71.8% to $99.4 million in 2016, then tumbled by 41.03% to $58.6 million in 2017, then fell by 25.25% to $43.8 million in 2018, then changed by 0.0% to $43.8 million in 2019.
  • Its last three reported values are $43.8 million in Q2 2019, $43.8 million for Q1 2019, and $43.8 million during Q4 2018.